Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126036102 | 12603610 | 2 | F | 20151223 | 20160728 | 20160801 | EXP | ES-KALEO, INC-2015SA219799 | KALEO | PEREZ-VILLAREJO GJ, MARTINEZ AD, MARTINEZ JCD, GONZALEZ JY, AURIOLES JC. EPINEPHRINE PRETREATMENT FOR PREVENTING POSTREPERFUSION SYNDROME COULD AGGRAVATE THIS SYNDROME AND SHOULD BE AVOID IN SOME CASES. TRANSPLANTATION. 2015 JUL;99(7 SUPPL 1):199. DOI: 10.1097/01.TP.0000469973.81769.3C | 53.00 | YR | UNK | Y | 0.00000 | 20160801 | OT | ES | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126036102 | 12603610 | 1 | PS | EPINEPHRINE. | EPINEPHRINE | 1 | Unknown | UNKNOWN, UNKNOWN | UNK | 201739 | 10 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126036102 | 12603610 | 1 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126036102 | 12603610 | LT |
| 126036102 | 12603610 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126036102 | 12603610 | Bradycardia | |
| 126036102 | 12603610 | Cardiomyopathy | |
| 126036102 | 12603610 | Condition aggravated | |
| 126036102 | 12603610 | Hypertension |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |